1 / 2

Adcetris: An antineoplastic drug

Brentuximab Vedotin is supplied as a sterile, white to off-white lyophilized, preservative-free cake or powder in a single-use vial for reconstitution. One should not mix Adcetris with or administer it as an infusion with other medicinal products. Adcetris comes in single-use vials in 50 mg to administer intravenously only. The drug Brentuximab vedotin is an ADC, and the antibody is a chimeric IgG1 directed against CD30. The antibody is produced by Chinese hamster ovary cells, and the small molecule components are produced by chemical synthesis. <br>There are various licensed suppliers of Adcetr

roma7
Download Presentation

Adcetris: An antineoplastic drug

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Adcetris: Hodgkin lymphoma and Anaplastic large cell lymphoma Adcetris is an FDA-approved medicine. Brentuximab Vedotin is the active ingredient in medicine which is an ADC. The antibody is a chimeric IgG1 directed against CD30. Healthcare professionals use this medicine in treating patients with: • Hodgkin lymphoma (HL), also called Hodgkin's disease, is a type of cancer that develops in the lymph system. Your lymph system is part of your immune system. It helps protect your body from infection and disease. • Systemic anaplastic large cell lymphoma (sALCL) is a rare type of blood cancer that occurs in white blood cells. Dosage and Administration •One should administer Adcetris as an intravenous infusion over 30 minutes every 3 weeks until disease progression or unacceptable toxicity. •One should administer Adcetris as an intravenous infusion only. •Do not mix Adcetris with, or administer as an infusion with, other medicinal products. This medicine is available in 50 mg in single-use vials to administer intravenously. Healthcare professionals should administer Adcetris injection as an intravenous infusion over 30 minutes every 3 weeks until disease progression or unacceptable toxicity. There is no known antidote for overdose of Adcetris. In case of overdosage, one should monitor the patient closely for adverse reactions, particularly neutropenia, and administer supportive treatment to the patient. Adcetris side-effects are: • Peripheral neuropathy • Fatigue • Nausea • Diarrhea • Neutropenia • upper respiratory tract infection • Pyrexia • Constipation • Vomiting • Alopecia • Decreased weight • Abdominal pain • Anemia • Stomatitis • Lymphopenia • Mucositis Brentuximab Vedotin Injection is supplied as a sterile, white to off-white preservative-free lyophilized cake or powder in individually-boxed single-use vials. One should store this medicine at 2–8°C (36–46°F) in the original carton to protect it from light. There are several certified and genuine suppliers of Adcetris, if you want to buy Brentuximab Vedotin in India contact toll-free no. 18008891064.

  2. FAQ What are the symptoms of Hodgkin Lymphoma? The symptoms of Hodgkin Lymphoma are: • Painless swelling of lymph nodes in your neck, armpits or groin • Persistent fatigue • Fever • Night sweats • Losing weight without trying • Severe itching • Pain in your lymph nodes after drinking alcohol Is Adcetris FDA approved? The FDA approved the medicine Adcetris in 2011 for treating patients who have Hodgkin lymphoma and Systemic anaplastic large cell lymphoma. Source - https://indianpharmanetwork.mystrikingly.com/blog/adcetris-hodgkin-lymphoma

More Related